AAAAAA

   
Results: 1-7 |
Results: 7
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer
Authors: Levitt, NC Eskens, FALM O'Byrne, KJ Propper, DJ Denis, LJ Owen, SJ Choi, L Foekens, JA Wilner, S Wood, JM Nakajima, M Talbot, DC Steward, WP Harris, AL Verweij, J
Citation: Nc. Levitt et al., Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer, CLIN CANC R, 7(7), 2001, pp. 1912-1922
Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors
Authors: Eskens, FALM Awada, A Cutler, DL de Jonge, MJA Luyten, GPM Faber, MN Statkevich, P Sparreboom, A Verweij, J Hanauske, AR Piccart, M
Citation: Falm. Eskens et al., Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors, J CL ONCOL, 19(4), 2001, pp. 1167-1175
Temozolomide chemotherapy in recurrent oligodendroglioma
Authors: van den Bent, MJ Keime-Guibert, F Brandes, AA Taphoorn, MJB Kros, JM Eskens, FALM Carpentier, AF
Citation: Mj. Van Den Bent et al., Temozolomide chemotherapy in recurrent oligodendroglioma, NEUROLOGY, 57(2), 2001, pp. 340-342
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors
Authors: Eskens, FALM Greim, GA van Zuylen, C Wolff, I Denis, LJ Planting, AST Muskiet, FA Wanders, J Barbet, NC Choi, L Capdeville, R Verweij, J Hanauske, AR Bruntsch, U
Citation: Falm. Eskens et al., Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors, CLIN CANC R, 6(5), 2000, pp. 1736-1743
Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor
Authors: Eskens, FALM Levitt, NC Sparreboom, A Choi, L Mather, R Verweij, J Harris, AL
Citation: Falm. Eskens et al., Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor, CLIN CANC R, 6(2), 2000, pp. 431-433
Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design
Authors: Eskens, FALM Verweij, J
Citation: Falm. Eskens et J. Verweij, Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design, CR R ONC H, 34(2), 2000, pp. 83-88
Farnesyl transferase inhibitors: current developments and future perspectives
Authors: Eskens, FALM Stoter, G Verweij, J
Citation: Falm. Eskens et al., Farnesyl transferase inhibitors: current developments and future perspectives, CANC TR REV, 26(5), 2000, pp. 319-332
Risultati: 1-7 |